Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers

Drug resistance continues to be a major problem associated with cancer treatment. One of the primary causes of anticancer drug resistance is the frequently mutated RAS gene. In particular, considerable efforts have been made to treat KRAS-induced cancers by directly and indirectly controlling the ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyun, Soonsil, Shin, Dongyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621880/
https://www.ncbi.nlm.nih.gov/pubmed/34830024
http://dx.doi.org/10.3390/ijms222212142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621880/
https://www.ncbi.nlm.nih.gov/pubmed/34830024
http://dx.doi.org/10.3390/ijms222212142

Ejemplares similares